Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-κB Signaling Pathways.

MLA

Yu, Duo, et al. “Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-ΚB Signaling Pathways.” Frontiers in Pharmacology, Sept. 2018, p. N.PAG. EBSCOhost, https://doi.org/10.3389/fphar.2018.01001.

APA

Yu, D., Liu, X., Zhang, G., Ming, Z., & Wang, T. (2018). Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-κB Signaling Pathways. Frontiers in Pharmacology, N.PAG. https://doi.org/10.3389/fphar.2018.01001

Chicago

Yu, Duo, Xueshibojie Liu, Guangxin Zhang, Zhihui Ming, and Tiejun Wang. 2018. “Isoliquiritigenin Inhibits Cigarette Smoke-Induced COPD by Attenuating Inflammation and Oxidative Stress via the Regulation of the Nrf2 and NF-ΚB Signaling Pathways.” Frontiers in Pharmacology, September, N.PAG. doi:10.3389/fphar.2018.01001.